Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Wisconsin for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Wisconsin only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Wisconsin (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jeffrey Weber (NPI 1962465047)

Field	Value
Entity Type	Individual
Organization	Jeffrey Weber
Address	2901 W. Kk River Pkwy.
City	Milwaukee
State	WI
ZIP	53215
Taxonomy	Gastroenterology Physician
NPI Enumerated	April 10, 2006

Payer Source	Total Paid
Medicare	$20.8M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-focused gastroenterology practice: reported Total Medicare revenue is $20.8M and there is no Medicaid billing on file, indicating a single-payer footprint in public programs. The NPI was enumerated on 2006-04-10 (~20 years ago), consistent with an established operation serving primarily Medicare or commercially insured patients rather than Medicaid populations.

Revenue is highly concentrated in a handful of high-cost injectable therapies: the precomputed top three codes (J2507, J1303, J3241) account for 51.0% of the provider's Medicare revenue. Those individual contributions are $4.1M (20.0%) for J2507, $3.7M (17.9%) for J1303, and $2.7M (13.1%) for J3241, which together drive the majority of billings and would shape service-line priorities and inventory/administration needs.

The code mix indicates the practice operates a high-volume infusion/injectable administration service focused on specialty biologics and related therapeutics rather than routine endoscopic procedural billing: prominent codes include pegloticase (J2507), ravulizumab (J1303), teprotumumab (J3241), vedolizumab (J3380), and multiple immune globulin codes. This pattern suggests clinical focus on chronic autoimmune, inflammatory bowel disease, anemia management, and other specialty injectable indications where office-based infusions are central to revenue.

Competitive standing on several leading codes shows national-level prominence: J2507 ranks #1 of 5 providers nationally (100th percentile; typical, unremarkable volume for this code) and J1303 ranks #1 of 2 providers nationally (100th percentile; typical, unremarkable volume for this code), while J3241 ranks #3 of 6 providers nationally (60th percentile; typical, unremarkable volume for this code). Those rank positions indicate the provider is among a small set of national billers for certain rare/expensive injectables, even if the dataset labels volumes as “typical, unremarkable” for those code populations.

Several codes are flagged as statistical outliers for unusually high national volume, which signals exceptional throughput in specific drug administrations: J0897 ($1.2M, 5.9%) is an "extreme outlier, far above typical national volume for this code" (rank #10 of 10057, 100th percentile), J3111 ($1.1M, 5.4%) is an "extreme outlier" (rank #8 of 970, 99th percentile), J1306 ($626.2K, 3.0%) is an "extreme outlier" (rank #8 of 462, 98th percentile), J1439 ($371.3K, 1.8%) is an "extreme outlier" (rank #2 of 1209, 100th percentile), and the administration code 96365 ($127.7K, 0.6%) is likewise an "extreme outlier" (rank #15 of 8873, 100th percentile).

Despite concentration in a few top drugs, revenue is diversified across many biologics and immunotherapies at smaller shares: examples include J9332 $1.4M (6.7%), J1561 $640.4K (3.1%), J3380 $601.8K (2.9%), and J9312 $563.2K (2.7%). This spread across multiple specialty agents suggests the practice provides infusion services for a broad set of indications, reducing dependence on any single therapeutic beyond the top three.

Operationally, the practice shows substantial infusion administration activity and capacity: 96365 appears with 2.7K claims and $127.7K revenue (0.6%) and 96413 has 401 claims and $38.9K revenue (0.2%), supporting the conclusion that an on-site infusion suite or regular outpatient infusion workflow underpins much of the billing. Combined with the high claim counts reported for many J-codes, these volumes imply routine, high-frequency administration rather than sporadic use.

From a payer-mix and market-access perspective, the absence of Medicaid billing coupled with a long-tenured NPI (enumerated 2006-04-10, ~20 years ago) suggests an established provider whose patient panel skews to Medicare-aged or commercially insured specialty patients. Analysts assessing network adequacy or access should note the practice’s strong Medicare presence ($20.8M) but no Medicaid footprint, which could limit public-program access in its market area.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

39 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2507	Injection, pegloticase, 1 mg	1,620	$2,550	$4.1M
J1303	Injection, ravulizumab-cwvz, 10 mg	21,350	$170	$3.7M
J3241	Injection, teprotumumab-trbw, 10 mg	10,600	$260	$2.7M
J9332	Injection, efgartigimod alfa-fcab, 2mg	55,600	$30	$1.4M
J0897	Injection, denosumab, 1 mg	67,440	$20	$1.2M
J3111	Injection, romosozumab-aqqg, 1 mg	139,020	$10	$1.1M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	16,420	$40	$640.4K
J1306	Injection, inclisiran, 1 mg	69,580	$10	$626.2K
J3380	Injection, vedolizumab, intravenous, 1 mg	35,400	$20	$601.8K
J9312	Injection, rituximab, 10 mg	8,940	$60	$563.2K

Showing 1–10 of 39

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 39 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Wisconsin Distribution

Jeffrey Weber — 12 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Wisconsin

Full comparison — all codes billed, vs. state median

39 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2507	1	10	1,620	$2,550	$4.1M
J1303	1	10	21,350	$170	$3.7M
J3241	1	10	10,600	$260	$2.7M
J9332	1	10	55,600	$20	$1.4M
J2350	2	10	10,800	$50	$576.1K
J3245	4	10	3,850	$110	$446.3K
J1306	1	10	37,770	$10	$353.5K
J0129	1	10	8,170	$30	$286.2K
J2182	1	10	10,600	$20	$248K
J3380	1	10	7,650	$20	$245.6K

Showing 1–10 of 39

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jeffrey Weber, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Violetta Melkum	AZ	Family Nurse Practitioner	$751.7K	$0
Madhuri Trivedi	WI	Gastroenterology Physician	$89.4K	$0

Nearby Providers

Other providers in the same ZIP code as Jeffrey Weber, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Aurora Health Care Metro, Inc.	WI	General Acute Care Hospital	$0	$181.9M
Aurora Medical Group, Inc.	WI	Certified Registered Nurse Anesthetist	$2.2K	$139.2M
Ascension St Francis Hospital, Inc	WI	General Acute Care Hospital	$0	$35.9M
Sixteenth Street Community Health Centers, Inc.	WI	Federally Qualified Health Center (FQHC)	$0	$13.8M
Familia Dental Mkemitchell LLC	WI	Dental Clinic/Center	$0	$8.5M
Ermed, Sc	WI	Emergency Medicine Physician	$0	$8.1M
Midwest Nephrology Associates, S.c.	WI	Nephrology Physician	$0	$5.7M
Bright Dental 1 LLC	WI	General Practice Dentistry	$0	$4.6M
Fresenius Medical Care Midwest Dialysis, LLC	WI	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$3.9M
Sweet Smiles Milwaukee LLC	WI	General Practice Dentistry	$0	$3.7M

Jeffrey Weber — Billing Profile & Reimbursement Data

Sign up for Jeffrey Weber — Billing Profile & Reimbursement Data policy alerts

Jeffrey Weber — Billing Profile & Reimbursement Data

Sign up for Jeffrey Weber — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References